|
|
 | | | |
- close
- close
- close
- close
Cell Therapeutics Inc (CTICD) |
StreetInsider.com
Nov 1
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Cell+Therapeutics+Inc.+%28CTIC%29+Narrows+Q3+Loss+to+38cShare/7833002.html for the full story.
StreetInsider.com
Aug 1
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Cell+Therapeutics+Inc.+%28CTIC%29+Widens+Q2+Loss+to+28cShare/7620340.html for the full story.
StreetInsider.com
Jul 28
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Cell+Therapeutics%2C+Inc.+%28CTIC%29+Narrows+Q2+Loss/6665614.html for the full story.
StreetInsider.com
Jun 1
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Cell+Therapeutics+%28CTICD%29+Regains+Nasdaq+Listing+Compliance/6550504.html for the full story.
Wall Street Sector Selector
May 26
Comment
Cell Therapeutics, Inc. (NASDAQ: CTICD) has long been a controversial stock. It has brought many rewards for investors and it has also brought much pain to investors. We recently featured its positive development in pixantrone with an appeal...
StreetInsider.com
May 26
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Cell+Therapeutics+%28CTICD%29+IDs+Potential+Immunotherapy+Drug+Candidate+Acquisition/6539830.html for the full story.
Penny Stock DD
May 24
Comment
Cell Therapeutics, Inc. (NASDAQ:CTICD) went up by 8.65% to close at $2.26 with overall traded volume of 13.95 million shares in the last trading day. The current market price is 5.27% more than its last 50 days simple moving average. The share...
Stock Wizard
May 23
Comment
Cell Therapeutics, Inc. (NASDAQ: CTICD) surged more than 11% after the company announced that it will meet with the U.S. Food and Drugs Administration's Office of Oncology Drug Products in early June to discuss the re-submission of CTI's New Drug...
Globe Newswire
Oct 19
Comment
DALLAS, Oct. 19, 2010 (GLOBE NEWSWIRE) -- MicroStockProfit.com announces an investment report featuring Cell Therapeutics Inc. (Nasdaq:CTIC). The report includes financial, comparative and investment analyses, and industry information you need to
Benzinga
Oct 14
Comment
Shares of Cell Therapeutics, Inc. (NASDAQ: CTIC) are higher on the session by 7.35%, currently trading at $0.4149. The stock has been moving largely lower for the past six months, though has recently begun to base sideways around the 200-day...
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS|
Error creating thumbnail: convert: unable to open image `/home/wikinvest/src_live_1/mediawiki/images/9/98/New_stock.png': No such file or directory @ blob.c/OpenBlob/2480. convert: unable to open file `/home/wikinvest/src_live_1/mediawiki/images/9/98/New_stock.png' @ png.c/ReadPNGImage/2889. convert: missing an image filename `/home/wikinvest/src_live_1/mediawiki/images/thumb/9/98/New_stock.png/35px-New_stock.png' @ convert.c/ConvertImageCommand/2800. |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
| |||||||
